Effect of Introduction of the Pneumococcal Conjugate Vaccine on Drug-Resistant Streptococcus pneumoniae
New England Journal of Medicine2006Vol. 354(14), pp. 1455–1463
Citations Over TimeTop 1% of 2006 papers
Moe H. Kyaw, Ruth Lynfield, William Schaffner, Allen S. Craig, James L. Hadler, Arthur Reingold, Ann Thomas, Lee H. Harrison, Nancy M. Bennett, Monica M. Farley, Richard R. Facklam, James H. Jorgensen, John M. Besser, Elizabeth R. Zell, Anne Schuchat, Cynthia G. Whitney
Abstract
The rate of antibiotic-resistant invasive pneumococcal infections decreased in young children and older persons after the introduction of the conjugate vaccine. There was an increase in infections caused by serotypes not included in the vaccine.
Related Papers
- → Multicenter Surveillance of Streptococcus pneumoniae Isolates From Middle Ear and Mastoid Cultures in the 13-Valent Pneumococcal Conjugate Vaccine Era(2015)68 cited
- → InvasiveStreptococcus pneumoniaein Children, Malawi, 2004–2006(2011)27 cited
- → Serotypes of Streptococcus pneumoniae Isolates from Children with Invasive Pneumococcal Disease in Turkey: Baseline Evaluation of the Introduction of the Pneumococcal Conjugate Vaccine Nationwide(2011)16 cited
- → Distribution and annual changes in the proportion of Streptococcus pneumoniae serotypes in Japanese adults with pneumococcal pneumonia from 2011 to 2017(2019)9 cited
- → The Case of Three Infants in Whom <i>Streptococcus pneumoniae </i>was Isolated from Their Blood After Inoculation with 7-valent Pneumococcal Conjugate Vaccine ―Importance of the Investigation of <i>Streptococcus pneumoniae </i>Serotype―(2014)